关于“质谱分析”的报告
-
-
-
艾媒咨询｜2021年中国美容美发行业投资机遇及总体趋势研究报告
数据显示，2015-2021年中国美容美发行业市场规模复合增长率为4.0%，2021年市场规模为3863亿元。随着国民生活水平的提高以及对生活品质的不断追求，美容美发业的消费需求旺盛，上下游产业和新兴业态快速发展，预估2022年中国美容美发行业市场规模将突破4000亿元。且值得注意的是，在备案完善、监督加强及违法经营成本提升的背景下，中国化妆品行业将加速整顿，有效保障产品安全及其功效的稳定性，具有较强研发实力的品牌有望占据更大的市场份额。随着新消费群体逐渐成为购买主力，不能快速响应市场的品牌面临淘汰，大规模企业兼并即将到来。
According to the data, the compound growth rate of the market scale of China's beauty salon industry from 2015 to 2021 was 4.0%, and the market scale in 2021 was 386.3 billion yuan. With the improvement of national living standards and the continuous pursuit of quality of life, the consumption demand of beauty salon industry is strong, and the upstream and downstream industries and emerging business forms are developing rapidly. It is estimated that the market scale of China's beauty salon industry will exceed 400 billion yuan in 2022. It is worth noting that under the background of perfect filing, strengthened supervision and increased illegal operating costs, China's cosmetics industry will accelerate the rectification and effectively ensure the stability of product safety and efficacy. Brands with strong R & D strength are expected to occupy a larger market share. As new consumer groups gradually become the main force of purchase, brands that cannot respond quickly to the market are facing elimination, and large-scale enterprise mergers are coming. -
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例：华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势，细胞生物临床研究不断深化，伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成，生态圈的完善将在很大限度上推动产业快速发展。数据显示，中国细胞治疗企业融资金额不断增加，从2014年的0.2亿元增长至2019年的28.9亿元。其中，2018年中国细胞治疗企业融资额同比增长706.8%，呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇，同时也有挑战并存。后续产业的发展，将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局，企业也应积极开展生态合作以及更为密切关注市场需求动向，将疗法和新一代医疗创新技术深度融合，实现市场产品多元化与差异化，并推出独特性的精准治疗，从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value. -
艾媒报告|2019-2020年中国移动社交行业年度研究报告
本报告研究涉及企业/品牌/案例：玩吧APP，Soul APP，积目APP；其他提及企业/品牌：微信，QQ，飞聊，微博，珍爱网，百度贴吧，豆瓣，知乎，小红书，陌陌，boss直聘，脉脉，钉钉，抖音，keep，绿洲，探探，糖豆，派派，多闪，我是谜
iiMedia Research（艾媒咨询）数据显示，2019上半年中国即时通信应用使用率达到96.9%， 即时通信所代表的移动社交已成网民生活常态，随着国内移动社交生态的发展，预计到2020年用户规模将突破9亿。庞大的移动社交用户规模也意味着更多的市场可能性，而以95后、00后为主的年轻新世代逐渐成为中国移动社交市场的主力军。这部分年轻用户更青睐于轻松、趣味社交形式， 偏好新潮、有趣、多元的社交场景。当前5G、人工智能、VR等技术的发展与变迁驱动音频、视频、直播等新型社交载体加速落地。在技术升级和用户需求提升的背景下，传统移动社交厂商和新入局者纷纷瞄准泛娱乐类社交、校园社交等移动社交细分领域。艾媒咨询分析师认为，在技术变迁、需求细化、厂商积极布局等因素驱动下，中国移动社交行业将迎来新一轮的变革契机。
iiMedia Research data shows that in the first half of 2019, the usage rate of instant messaging apps in China reached 96.9%, and the mobile social network represented by instant messaging has become the normal life of netizens. With the development of mobile social ecology in China, the user scale is expected to exceed 900 million by 2020. The large scale of mobile social users also means more market possibilities, and the younger generation, mainly the post-1995 and post-2000 generations, is gradually becoming the main force in China's mobile social market. This group of young users are more interested in relaxing and interesting social forms, and prefer trendy, interesting and diverse social scenes. The development and changes of 5G, artificial intelligence, VR and other technologies are accelerating the landing of new social carriers such as audio, video and live broadcast. Under the background of technology upgrading and user demand improvement, traditional mobile social network manufacturers and new entrants have targeted the mobile social segments such as pan-entertainment social network and campus social network. iimedia consulting analysts believe that Chinese mobile social networking industry will usher in a new round of opportunities for change driven by technological changes, demand refinement, active layout of manufacturers and other factors. -
艾媒报告|2020-2021年中国美容美发行业细分领域及总体趋势研究报告
本报告研究涉及企业/品牌/案例：星客多，完美日记，新氧医美；其他提及企业/品牌：海飞丝，阿道夫，沙宣，清扬，潘婷，飘柔，吕，多芬，施华蔻，资生堂，霸王，章光101，欧倍青，卡诗，滋源，丰添，馥绿德雅，索芙特，欧莱雅，花王，美源，爱茉莉，韩金靓，三橡树，利尻昆布，宣若，自然堂，百雀羚，珀莱雅，隆力奇，佰草集，丸美，相宜本草，薇诺娜，毛戈平，雅诗兰黛，兰蔻，SK-II，兰芝，佰草集，高丝，玉兰油、欧莱雅，欧泊莱，旁氏，大宝，郁美净，隆力奇，丁家宜，佳雪，In Style 造型，OnHair Salon，SWANK Salon，My Hair Salon，AUTHOR TNT ATELIER，藤野造型，木北造型，3AM Hair Salon，Amo la Diva 造型，bymiga，OnHair Salon，In Style 造型，藤野造型，P.STYLE 派斯造型，Hair Code 芭曲造型，MG Style Salon，Kraemer Paris 苏豪发廊，TL Hair 造型，3AM Hair Salon，IMPRES 印象美学，In Style 造型，Paya Hair，My Hair Salon，T SPACE 韩式发型，至 ACME STUDIOS，MJ Hair Style，On Star Salon，简发 HAIR 造型，L’Fashion 美发沙龙，AD Hair Salon，DL VOGUE，Cola-Pie 美发沙龙，原宿 Salon，Nice Salon，In Style 造型，OnHair Salon，Mirror Salon，3AM Hair Salon，COO Salon，MIG Salon等
2020年1月21日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国美容美发行业细分领域及总体趋势研究报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对中国美容美发行业的发展现状、用户行为和产业链细分领域进行深度分析，并且以新氧等上市公司作为典型案例进行商情分析，深入研究中国美容美发行业运行模式和发展趋势。2019年，中国的美容美发机构约有95%为民营资本，美容美发行业就业人口达2700万人;总体来说，中国美容美发业整体属于小投资、大市场型的服务行业。随着中国美容美发行业竞争愈发激烈，美容美发机构的经营模式正由单一走向综合，形式也日趋多样化，品牌机构趋向连锁加盟、互联网+实体店融合的经营模式发展。
The report conducts an in-depth analysis of the development status, user behavior and industry chain segmentation of China's beauty and hairdressing industry. Listed companies analyze business conditions as a typical case, and study in-depth the operation mode and development trend of China's beauty and hairdressing industry. In 2019, about 95% of China's beauty and hairdressing institutions are private capital, and the beauty and hairdressing industry employs 27 million people. In general, China's beauty and hairdressing industry as a whole is a small investment and large market-oriented service industry. As the competition in the Chinese beauty and hairdressing industry becomes more intense, the business model of the beauty and hairdressing organization is moving from a single to a comprehensive, and the form is becoming more and more diversified. -
艾媒研报|科创板：2019年科创板受理企业及影子股分析研究报告
本报告研究涉及企业/品牌包括：科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动、优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药
2019年3月份科创板受理的企业包括：科前生物、安翰科技、和舰芯片、容百科技、利元亨、江苏北人、天奈科技、睿创微纳、晶晨股份、贝斯达、华兴源创、微芯生物、特宝生物、国盾量子、虹软科技、世纪空间、光峰科技、福光股份、鸿泉物联、木瓜移动等 2019年4月份受理的企业包括：优刻得、博众精工、创鑫激光、聚辰股份、海尔生物、天准科技、晶丰明源、申联生物、南微医学、美迪西、紫晶存储、苑东生物、恒安嘉新、乐鑫科技、龙软科技、杰普特、热景生物、瀚川智能、威胜信息、安博通、铂力特、视联动力、博瑞医药等，相应的重点影子股包括： TCL集团、华域汽车、天风证券、通化东宝、千方科技等。
In March and April 2019, the science and technology innovation board accepted the following enterprises: Wuhan Keqian Biology Co,Ltd, Ankon Technologies Co. Ltd, Hejian Technology (Suzhou) Co, Ltd, Ningbo Ronbay New Energy Technology Co, Ltd, Guangdong Lyric Robot Automation Co, Ltd, Jiangsu Beiren Robot System Co,Ltd, Jiangsu Cnano Technology Co, Ltd,Raytron Technology Co,Ltd,Amlogic (Shanghai) Co,Ltd, Shenzhen Basda Medical Apparatus Co,Ltd,Suzhou Hyc Technology Co,Ltd , etc. In April 2019, the science and technology innovation board accepted the following enterprises: Montage Technology Co, Ltd, UCloud Technology Co, Ltd, Bozhon Precision Industry Technology Co,Ltd, Shanghai Shen Lian Biomedical Corporation, Shanghai Bright Power Semiconductor Co, Ltd, Suzhou Tztek Technology Co,Ltd, Giantec Semiconductor Corporation, QINGDAO HAIER BIOMEDICAL CO, LTD. , MAXPHOTONICS Co, Ltd, Amethystum Storage Technology Co,Ltd , etc. -
艾媒报告 |2019年猎聘同道APP产品分析及用户洞察研究报告
本报告研究涉及企业/品牌包括:智联招聘、前程无忧、58同城、赶集网、拉勾网、脉脉、大街、BOSS直聘、斗米、兼职猫、招财猫直聘、店长直聘、中华英才网、领英、应届生求职网、智通人才
iiMedia Research(艾媒咨询)监测发现，猎聘同道的月活跃用户量为154.91万，在艾媒北极星求职招聘APP中排名第六，在垂直招聘类APP排名中继续稳坐首席，猎聘同道的成功，很大程度得益于其较为强大的猎头服务和较为精准的市场定位。然而，随着招聘行业逐渐进入成熟阶段，各大求职招聘类APP的用户渗透率总体平稳;新形势下，对于求职招聘类APP而言，深耕市场，提高服务或许才是唯一的出路。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry. -
- 1
- 2
